207 related articles for article (PubMed ID: 17315533)
1. Hypophosphatemic rickets in opsismodysplasia.
Zeger MD; Adkins D; Fordham LA; White KE; Schoenau E; Rauch F; Loechner KJ
J Pediatr Endocrinol Metab; 2007 Jan; 20(1):79-86. PubMed ID: 17315533
[TBL] [Abstract][Full Text] [Related]
2. Plasma intact fibroblast growth factor 23 level is a useful tool for diagnostic approach of renal hypophosphatemia.
Giralt M; Chocron S; Ferrer R; Ariceta G
Pediatr Nephrol; 2021 Apr; 36(4):1025-1028. PubMed ID: 33492457
[TBL] [Abstract][Full Text] [Related]
3. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.
Imel EA; DiMeglio LA; Hui SL; Carpenter TO; Econs MJ
J Clin Endocrinol Metab; 2010 Apr; 95(4):1846-50. PubMed ID: 20157195
[TBL] [Abstract][Full Text] [Related]
4. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
Weber TJ; Liu S; Indridason OS; Quarles LD
J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
[TBL] [Abstract][Full Text] [Related]
5. Contribution of imaging to the diagnosis and follow up of X-linked hypophosphatemia.
Adamsbaum C; Laredo JD; Briot K; Linglart A
Arch Pediatr; 2021 Oct; 28(7):594-598. PubMed ID: 34583869
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of patients with FGF23-related hypophosphatemic rickets.
Kinoshita Y; Saito T; Shimizu Y; Hori M; Taguchi M; Igarashi T; Fukumoto S; Fujita T
Eur J Endocrinol; 2012 Aug; 167(2):165-72. PubMed ID: 22577109
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.
Brown WW; Jüppner H; Langman CB; Price H; Farrow EG; White KE; McCormick KL
J Clin Endocrinol Metab; 2009 Jan; 94(1):17-20. PubMed ID: 18854401
[TBL] [Abstract][Full Text] [Related]
8. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.
Econs MJ; McEnery PT
J Clin Endocrinol Metab; 1997 Feb; 82(2):674-81. PubMed ID: 9024275
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
[TBL] [Abstract][Full Text] [Related]
10. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.
Imel EA; Hui SL; Econs MJ
J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222
[TBL] [Abstract][Full Text] [Related]
11. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
Goldsweig BK; Carpenter TO
Curr Osteoporos Rep; 2015 Apr; 13(2):88-97. PubMed ID: 25620749
[TBL] [Abstract][Full Text] [Related]
12. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
Kinoshita Y; Fukumoto S
Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
[TBL] [Abstract][Full Text] [Related]
13. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets.
Sun Y; Wang O; Xia W; Jiang Y; Li M; Xing X; Hu Y; Liu H; Meng X; Zhou X
J Bone Miner Metab; 2012 Jan; 30(1):78-84. PubMed ID: 21710177
[TBL] [Abstract][Full Text] [Related]
14. C-Terminal Fibroblast Growth Factor-23 Levels in Non-Nutritional Hypophosphatemic Rickets.
Bharati J; Bhatia D; Khandelwal P; Gupta N; Sinha A; Khadgawat R; Hari P; Bagga A
Indian J Pediatr; 2019 Jun; 86(6):555-557. PubMed ID: 30835073
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
Liu S; Gupta A; Quarles LD
Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
[TBL] [Abstract][Full Text] [Related]
16. High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH.
Igaki JM; Yamada M; Yamazaki Y; Koto S; Izawa M; Ariyasu D; Suzuki E; Hasegawa H; Hasegawa Y
Endocr J; 2011; 58(8):647-55. PubMed ID: 21597229
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of FGF23-related hypophosophatemic diseases].
Endo I
Clin Calcium; 2016 Feb; 26(2):223-31. PubMed ID: 26813502
[TBL] [Abstract][Full Text] [Related]
18. Polyostotic osteolysis and hypophosphatemic rickets with elevated serum fibroblast growth factor 23: A case report.
Sato T; Muroya K; Asakura Y; Yachie A; Nishimura G; Aida N; Machida J; Tanaka Y; Hasegawa T; Adachi M
Am J Med Genet A; 2015 Oct; 167A(10):2430-4. PubMed ID: 26059403
[TBL] [Abstract][Full Text] [Related]
19. [Chronic bone pain due to raised FGF23 production? The importance of determining phosphate levels].
de Jongh RT; Vervloet MG; Bravenboer N; Heijboer AC; den Heijer M; Lips P
Ned Tijdschr Geneeskd; 2013; 157(28):A5908. PubMed ID: 23841927
[TBL] [Abstract][Full Text] [Related]
20. Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets.
Xia W; Meng X; Jiang Y; Li M; Xing X; Pang L; Wang O; Pei Y; Yu LY; Sun Y; Hu Y; Zhou X
Calcif Tissue Int; 2007 Dec; 81(6):415-20. PubMed ID: 18046499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]